CSX vs IMNM · P/E 19, rev $7.42B vs $2.47B cap
CSX Corporation (CSX) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported CSX revenue for 2026-06-30 was $7.42B. Net income was $1.81B. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the CSX and IMNM stock pages for the full models.
Not investment advice.